Literature DB >> 6110451

Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets.

J A Grant, M C Scrutton.   

Abstract

1 The selectivity of alpha-adrenoceptors mediating the pro-aggregatory response of human and rabbit platelets to adrenaline and the conditions required to permit expression of an aggregatory response to partial agonists at these alpha-adrenoceptors have been studied.2 Yohimbine causes effective blockade of the pro-aggregatory responses whereas indoramin and prazosin are ineffective.3 The clonidine analogue, UK-14304, is nearly as effective as adrenaline in inducing an aggregatory response in human platelets and a pro-aggregatory response in rabbit platelets. Cross-tachyphylaxis between adrenaline and UK-14304 has been demonstrated.4 Clonidine is a weak agonist for the pro-aggregatory response of rabbit platelets and in some donors for the aggregatory response of human platelets.5 Methoxamine induces a pro-aggregatory response in human platelets which is blocked by indoramin or prazosin but not by yohimbine. No such response to methoxamine is observed in rabbit platelets.6 The divalent cation ionophore, A-23187, induces an aggregatory response to clonidine (in platelets from a non-responsive donor), phenylephrine and methoxamine in human platelets and to adrenaline, UK-14304 and clonidine in rabbit platelets. A secretory response to clonidine is also induced by A-23187 in human platelets.7 The adenylate cyclase inhibitor, SQ-22536, is ineffective in either inducing a response to the alpha-agonists or potentiating the effect of A-23187.8 The aggregatory responses to adrenaline and UK-14304 in rabbit platelets and to clonidine in human and rabbit platelets, which can be induced by A-23187, are blocked by yohimbine but not by prazosin or indoramin.9 From these studies we conclude that the pro-aggregatory responses of human and rabbit platelets to adrenaline are mediated primarily by alpha(2)-adrenoceptors. The presence of alpha(1)-adrenoceptors on human platelets is confirmed but these receptors do not appear to be present on rabbit platelets. The conditions required for expression of an aggregatory response to partial agonists at the human and rabbit platelet alpha-adrenoceptors implicate an increase in cytosolic Ca(2+) concentration as a key event in stimulus-response coupling but do not indicate such a role for depression of cyclic adenosine-3',5'-monophosphate concentration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6110451      PMCID: PMC2044410          DOI: 10.1111/j.1476-5381.1980.tb10917.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors.

Authors:  J C Doxey; C F Smith; J M Walker
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

2.  Roles of cyclic nucleotides in platelet function.

Authors:  R J Haslam
Journal:  Ciba Found Symp       Date:  1975

Review 3.  Prostaglandins and platelet function.

Authors:  E W Salzman
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

4.  Pharmacological classification of adrenergic alpha receptors in the guinea pig.

Authors:  J E Wikberg
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

5.  alpha-Adrenergic-mediated accumulation of adenosine 3':5' monophosphate in calcium-depleted hepatocytes.

Authors:  T M Chan; J H Exton
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

6.  Stimulation of adenosine 3',5'-monophosphate formation by alpha and beta adrenergic agonists in rat cerebral cortical slices: effects of clonidine.

Authors:  P Skolnick; J W Daly
Journal:  Mol Pharmacol       Date:  1975-09       Impact factor: 4.436

7.  Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.

Authors:  K Starke; T Endo; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

8.  Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptors.

Authors:  G M Drew
Journal:  Eur J Pharmacol       Date:  1976-04       Impact factor: 4.432

9.  Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.

Authors:  K D Newman; L T Williams; N H Bishopric; R J Lefkowitz
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

10.  Central nervous system depressant actions of clonidine and UK-14,304: partial dissociation of EEG and behavioural effects.

Authors:  H Ashton; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

View more
  22 in total

1.  Platelet in vitro responses to urapidil and prazosin.

Authors:  C C Smith; D J Betteridge; B N Prichard
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Alpha 2-adrenoceptor agonists enhance vasoconstrictor responses to alpha 1-adrenoceptor agonists in the rat tail artery by increasing the influx of Ca2+.

Authors:  X H Xiao; M J Rand
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

3.  Alpha 2-adrenoceptor agonists enhance responses to certain other vasoconstrictor agonists in the rat tail artery.

Authors:  X H Xiao; M J Rand
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

4.  [3H] UK-14,304, a new agonist ligand of alpha 2-adrenoceptors: a comparative study with human and rat tissue.

Authors:  H Rommelspacher; S Strauss; E Fähndrich; H J Haug
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

5.  Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.

Authors:  M Schattner; A Parini; F Fouque; B B Vargaftig; L Touqui
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

6.  Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.

Authors:  F Fouque; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

7.  Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat.

Authors:  A G Dupont; R A Lefebvre; M G Bogaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

8.  Mammalian platelet adrenoceptors.

Authors:  R Kerry; M C Scrutton; R B Wallis
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

9.  Regulation of adrenergic receptor number following chronic noradrenaline infusion in the rabbit.

Authors:  N M Deighton; A D Brown; C A Hamilton; J L Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

10.  Effect of 781094, a new selective alpha-adrenoceptor antagonist, on the aggregatory responses of human blood platelets and on binding of [3H]-dihydroergocryptine to these cells.

Authors:  R Kerry; M C Scrutton
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.